Thierry Guillaudeux - Dec 16, 2022 Form 4 Insider Report for KINETA, INC./DE (KA)

Role
Chief Scientific Officer
Signature
/s/ Pauline Kenny, as Attorney-in-Fact
Stock symbol
KA
Transactions as of
Dec 16, 2022
Transactions value $
$0
Form type
4
Date filed
12/20/2022, 07:56 PM
Next filing
Apr 14, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KA Common Stock Award +1.38K 1.38K Dec 16, 2022 Direct F1, F2
transaction KA Common Stock Award +10.3K +750% 11.7K Dec 16, 2022 Direct F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KA Stock Option (Right to Buy) Award +2.75K 2.75K Dec 16, 2022 Common Stock 2.75K $27.03 Direct F5, F6
transaction KA Stock Option (Right to Buy) Award +8.6K 8.6K Dec 16, 2022 Common Stock 8.6K $26.16 Direct F7, F8
transaction KA Stock Option (Right to Buy) Award +5.16K 5.16K Dec 16, 2022 Common Stock 5.16K $29.06 Direct F9, F10
transaction KA Stock Option (Right to Buy) Award +10.3K 10.3K Dec 16, 2022 Common Stock 10.3K $26.16 Direct F11, F12
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of Common Stock underlying a time-based restricted stock unit award ("RSU"). The RSU will vest in full on June 14, 2023, subject to the continuing employment of the Reporting Person on such vesting date.
F2 Received in connection with the Issuer's merger (the "Merger") with Kineta, Inc. ("Legacy Kineta") in accordance with the terms of the Agreement and Plan of Merger dated as of June 5, 2022, as amended on December 5, 2022 (the "Merger Agreement"), by and among the Issuer (f/k/a Yumanity Therapeutics, Inc.), Yacht Merger Sub, Inc. and Legacy Kineta. The Merger closed on December 16, 2022. Pursuant to the terms of the Merger Agreement, each outstanding share of Legacy Kineta common stock was entitled to receive 0.0688 shares of Common Stock. The RSU was received in exchange for 20,000 shares of common stock underlying a Legacy Kineta RSU.
F3 Represents shares of Common Stock underlying a time-based RSU. Effective as of June 14, 2023 (180 days following the Merger), the RSU will be vested as to 1/2 of the total number of shares and will continue to vest as to an additional 1/4 of the total number of shares on each of May 26, 2023 and May 26, 2024, subject to the continuing employment of the Reporting Person on each vesting date.
F4 Received in connection with the Merger in exchange for 150,000 shares of common stock underlying a Legacy Kineta RSU.
F5 The stock option will vest in four equal annual installments beginning on May 31, 2023, subject to the continuing employment of the Reporting Person on each vesting date.
F6 Received in connection with the Merger in exchange for options to acquire 40,000 shares of Legacy Kineta common stock for $1.86 per share.
F7 The stock option will vest in four equal annual installments beginning on March 18, 2023, subject to the continuing employment of the Reporting Person on each vesting date.
F8 Received in connection with the Merger in exchange for options to acquire 125,000 shares of Legacy Kineta common stock for $1.80 per share.
F9 The stock option vested as to 1/4 of the total number of shares on each of September 1, 2020, September 1, 2021 and September 1, 2022, and the remaining 1/4 of the total number of shares will vest on September 1, 2023, subject to the continuing employment of the Reporting Person on each vesting date.
F10 Received in connection with the Merger in exchange for options to acquire 75,000 shares of Legacy Kineta common stock for $2.00 per share.
F11 The stock option vested as to 1/4 of the total number of shares on May 27, 2022, and an additional 1/4 of the total number of shares will vest on each yearly anniversary thereafter, until such time as the stock option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.
F12 Received in connection with the Merger in exchange for options to acquire 150,000 shares of Legacy Kineta common stock for $1.80 per share.